All changes for the tissue respiratory system (187)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1664
carbohydrate sulfotransferase 2
Molecular
lung
Mouse
Chst2
10.0% Decrease Gene Expression Level
DAA1607
carbonic anhydrase 2
Molecular
lung
Mouse
Car2
5.0% Decrease Gene Expression Level
DAA1689
CD163 antigen
Molecular
lung
Mouse
Cd163
28.0% Increase Gene Expression Level
DAA1656
CD28 antigen
Molecular
lung
Mouse
Cd28
17.0% Increase Gene Expression Level
DAA1701
CD8 antigen, beta chain 1
Molecular
lung
Mouse
Cd8b1
36.0% Increase Gene Expression Level
DAA1619
cDNA sequence BC048546
Molecular
lung
Mouse
BC048546
18.0% Increase Gene Expression Level
DAA1705
cellular repressor of E1A-stimulated genes 1
Molecular
lung
Mouse
Creg1
3.0% Increase Gene Expression Level
DAA1561
chemokine (C-X-C motif) ligand 13
Molecular
lung
Mouse
Cxcl13
20.0% Increase Gene Expression Level
DAA1681
chemokine (C-X-C motif) ligand 14
Molecular
lung
Mouse
Cxcl14
8.0% Decrease Gene Expression Level
DAA1618
chemokine (C-X-C motif) receptor 3
Molecular
lung
Mouse
Cxcr3
20.0% Increase Gene Expression Level
DAA1604
chloride channel 3
Molecular
lung
Mouse
Clcn3
3.0% Increase Gene Expression Level
DAA1675
chondroitin sulfate synthase 1
Molecular
lung
Mouse
Chsy1
5.0% Decrease Gene Expression Level
DAA633
Chronic lower respiratory diseases
Pathological
respiratory system
Human
—
SeriesMorbidity
DAA1013
Chronic Obstructive Pulmonary Disease (Female)
Pathological
lung
Human
—
SeriesIncidence
DAA821
Chronic obstructive pulmonary disease incidence increases
Pathological
lung
Human
—
—
DAA1012
Chronic Obstructive Pulmonary Disease (Male)
Pathological
lung
Human
—
SeriesIncidence
DAA1703
CKLF-like MARVEL transmembrane domain containing 8
Molecular
lung
Mouse
Cmtm8
5.0% Decrease Gene Expression Level
DAA1655
coagulation factor XIII, A1 subunit
Molecular
lung
Mouse
F13a1
8.0% Increase Gene Expression Level
DAA1609
collagen, type I, alpha 2
Molecular
lung
Mouse
Col1a2
11.0% Decrease Gene Expression Level
DAA1603
collagen, type III, alpha 1
Molecular
lung
Mouse
Col3a1
11.0% Decrease Gene Expression Level
DAA1589
collagen, type VI, alpha 3
Molecular
lung
Mouse
Col6a3
9.0% Decrease Gene Expression Level
DAA1702
collagen, type XVI, alpha 1
Molecular
lung
Mouse
Col16a1
8.0% Decrease Gene Expression Level
DAA1637
collagen, type XXVII, alpha 1
Molecular
lung
Mouse
Col27a1
4.0% Decrease Gene Expression Level
DAA799
Compliance of parenchyma increases
Physiological
lung
Human
—
—
DAA1605
component of Sp100-rs
Molecular
lung
Mouse
Csprs
27.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1664 | carbohydrate sulfotransferase 2 | Molecular | lung | Mouse | Chst2 | 10.0% Decrease Gene Expression Level | |
DAA1607 | carbonic anhydrase 2 | Molecular | lung | Mouse | Car2 | 5.0% Decrease Gene Expression Level | |
DAA1689 | CD163 antigen | Molecular | lung | Mouse | Cd163 | 28.0% Increase Gene Expression Level | |
DAA1656 | CD28 antigen | Molecular | lung | Mouse | Cd28 | 17.0% Increase Gene Expression Level | |
DAA1701 | CD8 antigen, beta chain 1 | Molecular | lung | Mouse | Cd8b1 | 36.0% Increase Gene Expression Level | |
DAA1619 | cDNA sequence BC048546 | Molecular | lung | Mouse | BC048546 | 18.0% Increase Gene Expression Level | |
DAA1705 | cellular repressor of E1A-stimulated genes 1 | Molecular | lung | Mouse | Creg1 | 3.0% Increase Gene Expression Level | |
DAA1561 | chemokine (C-X-C motif) ligand 13 | Molecular | lung | Mouse | Cxcl13 | 20.0% Increase Gene Expression Level | |
DAA1681 | chemokine (C-X-C motif) ligand 14 | Molecular | lung | Mouse | Cxcl14 | 8.0% Decrease Gene Expression Level | |
DAA1618 | chemokine (C-X-C motif) receptor 3 | Molecular | lung | Mouse | Cxcr3 | 20.0% Increase Gene Expression Level | |
DAA1604 | chloride channel 3 | Molecular | lung | Mouse | Clcn3 | 3.0% Increase Gene Expression Level | |
DAA1675 | chondroitin sulfate synthase 1 | Molecular | lung | Mouse | Chsy1 | 5.0% Decrease Gene Expression Level | |
DAA633 | Chronic lower respiratory diseases | Pathological | respiratory system | Human | — | SeriesMorbidity | |
DAA1013 | Chronic Obstructive Pulmonary Disease (Female) | Pathological | lung | Human | — | SeriesIncidence | |
DAA821 | Chronic obstructive pulmonary disease incidence increases | Pathological | lung | Human | — | — | |
DAA1012 | Chronic Obstructive Pulmonary Disease (Male) | Pathological | lung | Human | — | SeriesIncidence | |
DAA1703 | CKLF-like MARVEL transmembrane domain containing 8 | Molecular | lung | Mouse | Cmtm8 | 5.0% Decrease Gene Expression Level | |
DAA1655 | coagulation factor XIII, A1 subunit | Molecular | lung | Mouse | F13a1 | 8.0% Increase Gene Expression Level | |
DAA1609 | collagen, type I, alpha 2 | Molecular | lung | Mouse | Col1a2 | 11.0% Decrease Gene Expression Level | |
DAA1603 | collagen, type III, alpha 1 | Molecular | lung | Mouse | Col3a1 | 11.0% Decrease Gene Expression Level | |
DAA1589 | collagen, type VI, alpha 3 | Molecular | lung | Mouse | Col6a3 | 9.0% Decrease Gene Expression Level | |
DAA1702 | collagen, type XVI, alpha 1 | Molecular | lung | Mouse | Col16a1 | 8.0% Decrease Gene Expression Level | |
DAA1637 | collagen, type XXVII, alpha 1 | Molecular | lung | Mouse | Col27a1 | 4.0% Decrease Gene Expression Level | |
DAA799 | Compliance of parenchyma increases | Physiological | lung | Human | — | — | |
DAA1605 | component of Sp100-rs | Molecular | lung | Mouse | Csprs | 27.0% Increase Gene Expression Level |